新易盛(300502.SZ):在LPO技術領域已深入佈局
格隆匯5月8日丨有投資者在投資者互動平台向新易盛(300502.SZ)提問,“請問貴司LPO開始供貨沒有?什麼時候開始批量供貨的?”
新易盛回覆稱,公司在LPO技術領域已深入佈局,在今年3月的OFC 2023期間推出了多款相關產品。LPO產品最終的上量情況將取決於市場的需求,公司已與產業鏈上下游開展了緊密合作,與主流廠商和用户建立起了良好合作關係,並積極推動LPO相關項目的進展,力爭在LPO相關產品的競爭中佔得先機。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.